Antibiotics specialist Antabio SAS has raised €25m in a Series B financing round with subscriptions from the AMR Action Fund, the EIC Fund and from existing investors.
https://european-biotechnology.com/wp-content/uploads/2024/04/investment__c__Nature_Design.jpeg8531280Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2023-12-12 13:11:112024-07-09 13:06:33Antabio SAS raises €25 m in Series B financing